A new discovery made by researchers from The Australian National University (ANU) could lead to smarter, more effective ...

Rash isn’t the most common symptom of Hodgkin lymphoma, but oncologists say it can happen. “This is often a rash that will ...

A multidrug regimen containing brentuximab vedotin (BV, Adcetris) proved feasible for older patients with advanced classical ...

The current standard treatment for relapsed or refractory Hodgkin’s lymphoma involves salvage chemotherapy followed by high-dose chemotherapy and sequential autologous stem cell transplantation.

This paper aims to provide a comprehensive and systematic analysis of the molecular mechanisms underlying lymphoma and to examine current therapeutic strategies with particular emphasis on the ...

Background Since Hodgkin lymphoma often afflicts young people and highly effective treatments allow most patients to survive long after their diagnosis, curing the disease has to be weighed against ...

High-dose chemotherapy with autologous stem cell support (HDT) has been proven effective in relapsed aggressive non-Hodgkin lymphoma (NHL). However, conflicting results of HDT as part of first-line ...

Our findings suggest that cell therapy using iPSC-derived, gene-modified natural killer cells in combination with monoclonal antibody and IL-2 is safe and active in B-cell malignancies and might ...